Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

Sponsor
The University of Texas Health Science Center, Houston
Status
Active, not recruiting
NCT ID
NCT04920097
The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by integrating self-report measures, psychophysical measures (QST), endogenous biomarkers (cytokines), and neuro-imaging to investigate APA's efficacy and underlying mechanism(s).
Intervention
In-person training for seed placement and APA, Post-training zoom session for seed placement and APA coaching, Usual Care, Virtual training for seed placement and APA
Condition
Chemotherapy-induced Neuropathy
Investigators
Constance Johnson, PhD, MS, RN, Nada Lukkahatai, PHD, MSN, RN

See list of participating sites